Acorn Financial Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Acorn Financial Advisory Services's PFE Position: Q2 2026 in Review
Acorn Financial Advisory Services sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,543 shares — an estimated $240K sold.
Acorn Financial Advisory Services first reported a position in PFE in Q4 2019 and held it in 24 quarters. The position peaked at $404K in Q2 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Acorn Financial Advisory Services reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Acorn Financial Advisory Services sold 8,543 Pfizer shares in Q2 2026, an estimated $240K.
- Acorn Financial Advisory Services first reported a position in Pfizer in Q4 2019 and held it in 24 quarters.
- Acorn Financial Advisory Services's Pfizer position peaked at $404K in Q2 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Acorn Financial Advisory Services's 13F filing for Q2 2026, filed 20 Jul 2026.